ZIM LABORATORIES Fact Sheet, ZIM LABORATORIES Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES Fact Sheet    (ZIML)


FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth


Here is the latest financial fact sheet of ZIM LABORATORIES. For more details, see the ZIM LABORATORIES quarterly results and ZIM LABORATORIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

ZIM LABORATORIES Price History

Price Rs 115.0
Mkt Cap Rs m 1,867
Vol '000 0.8
P/E X 29.7
P/CF X 8.1
EPS (TTM) Rs 3.9
% ch % -1.7
No. of shares m 16.24
% ch week % -8.1
% ch 1-mth % -11.7
% ch 12-mth % 28.3
52 week H/L Rs 189.5/68.6
(As on Dec 1, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ZIM LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
ZIM LABORATORIES EQUITY SHARE DATA
High RsNANA480149131 
Low RsNANA1174253 
Sales per share (Unadj.) Rs285.3336.6208.0171.7189.2 
Earnings per share (Unadj.) Rs23.123.79.52.04.5 
Diluted earnings per shareRs11.411.89.42.04.5 
Cash flow per share (Unadj.) Rs34.435.916.610.914.2 
Dividends per share (Unadj.) Rs01.000.5000 
Adj. dividends per shareRs0.000.500.500.000.00 
Avg Dividend yield %NMNM0.200 
Book value per share (Unadj.) Rs146.5168.893.094.899.0 
Adj. book value per shareRs72.483.792.394.599.0 
Shares outstanding (eoy) m8.038.0616.1216.1816.24 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x001.40.60.5 
Avg P/E ratio x0031.446.920.5 
P/CF ratio (eoy) x0018.08.76.5 
Price / Book Value ratio x003.21.00.9 
Dividend payout %04.25.300 
Avg Mkt Cap Rs m004,8141,5441,497 
No. of employees `000NANANANANA 
Total wages/salary Rs m330408483353358 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ZIM LABORATORIES INCOME DATA
Net Sales Rs m2,2912,7133,3542,7773,073 
Other income Rs m5534204523 
Total revenues Rs m2,3462,7483,3742,8233,096 
Gross profit Rs m315406420226346 
Depreciation Rs m9098114144158 
Interest Rs m10593106127109 
Profit before tax Rs m1752492211102 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-115867-3229 
Profit after tax Rs m1861911533373 
Gross profit margin %13.715.012.58.111.3 
Effective tax rate %-6.223.430.5-4,678.328.5 
Net profit margin %8.17.04.61.22.4 
ZIM LABORATORIES BALANCE SHEET DATA
Current assets Rs m1,5381,7291,9531,8201,918 
Current liabilities Rs m1,1321,4141,5641,4341,420 
Net working cap to sales %17.711.611.613.916.2 
Current ratio x1.41.21.21.31.4 
Inventory Days Days526141616 
Debtors Days Days141120101893858 
Net fixed assets Rs m9591,2171,3241,3791,304 
Share capital Rs m8081161162162 
"Free" reserves Rs m1,0961,2801,3381,3731,445 
Net worth Rs m1,1761,3601,4991,5351,608 
Long term debt Rs m275203222274218 
Total assets Rs m2,4962,9463,2773,2003,222 
Interest coverage x2.73.73.11.01.9 
Debt to equity ratio x0.20.10.10.20.1 
Sales to assets ratio x0.90.91.00.91.0 
Return on assets %11.69.77.95.05.7 
Return on equity %15.814.110.22.14.6 
Return on capital %19.321.919.07.011.6 
Exports to sales %53.7062.057.667.4 
Imports to sales %6.3010.34.64.1 
Exports (fob) Rs m1,23102,0791,6002,072 
Imports (cif) Rs m1440345128127 
Fx inflow Rs m1,23202,0791,6972,140 
Fx outflow Rs m3220345128127 
Net fx Rs m91001,7341,5692,012 
ZIM LABORATORIES CASH FLOW
From Operations Rs m 321 367 349 219 319 
From Investments Rs m -72 -258 -207 -194 -59 
From Financial Activity Rs m -251 -98 -152 -22 -260 
Net Cashflow Rs m -3 10 -10 10 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 33.3%
Institution 0.0%
Non-Institution 66.7%
Total 100.0%
Free Float 66.7%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Sadoday Gyan (Ground Floor) Opp. Nadt, Nelson Square, Nagpur - 440013
E-MAIL infa@zimlab.in WEB www.zimlab.in
TEL 0712-2588070 FAX
SECTOR PHARMACEUTICALS GROUP MNC
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1984 BSE CODE: 541400 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   LAURUS LABS   J.B.CHEMICALS  COMBAT DRUGS  NEULAND LABS  ISHITA DRUGS  

Compare ZIM LABORATORIES With:   LAURUS LABS   J.B.CHEMICALS  COMBAT DRUGS  NEULAND LABS  ISHITA DRUGS  




Today's Market

SGX Nifty Down 62 Points, M&M Tractor Sales, Nykaa's Expansion Plan, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices displayed a positive bias yesterday backed by supportive global cues and encouraging macro-economic data.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 8-QTR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS